Tianjin Tianyao Pharmaceuticals Co., Ltd.

XSSC:600488 Stock Report

Market Cap: CN¥4.8b

Tianjin Tianyao Pharmaceuticals Balance Sheet Health

Financial Health criteria checks 6/6

Tianjin Tianyao Pharmaceuticals has a total shareholder equity of CN¥3.9B and total debt of CN¥772.5M, which brings its debt-to-equity ratio to 20%. Its total assets and total liabilities are CN¥6.0B and CN¥2.1B respectively. Tianjin Tianyao Pharmaceuticals's EBIT is CN¥232.6M making its interest coverage ratio 10.6. It has cash and short-term investments of CN¥818.4M.

Key information

20.0%

Debt to equity ratio

CN¥772.48m

Debt

Interest coverage ratio10.6x
CashCN¥818.43m
EquityCN¥3.86b
Total liabilitiesCN¥2.13b
Total assetsCN¥5.99b

Recent financial health updates

No updates

Recent updates

Financial Position Analysis

Short Term Liabilities: 600488's short term assets (CN¥2.1B) exceed its short term liabilities (CN¥1.4B).

Long Term Liabilities: 600488's short term assets (CN¥2.1B) exceed its long term liabilities (CN¥699.1M).


Debt to Equity History and Analysis

Debt Level: 600488 has more cash than its total debt.

Reducing Debt: 600488's debt to equity ratio has reduced from 24.7% to 20% over the past 5 years.

Debt Coverage: 600488's debt is well covered by operating cash flow (99.9%).

Interest Coverage: 600488's interest payments on its debt are well covered by EBIT (10.6x coverage).


Balance Sheet


Discover healthy companies